Patent details

EP1974747 Title: Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody

Basic Information

Publication number:
EP1974747
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP080059215
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
French Title of Invention:
Polythérapies pour lymphomes B comprenant l'administration d'un anticorps anti-CD20
German Title of Invention:
Kombinationstherapien für B-Zellen-Lymphome mit Verabreichung eines Anti-CD20-Antikörpers
SPC Number:

Dates

Filing date:
11/08/1999
Grant date:
27/06/2012
EP Publication Date:
27/06/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/10/2008
EP B1 Publication Date:
27/06/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/08/2019
Renunciation date:
Revocation date:
21/04/2014
Annulment date:

Owner

From:
11/08/1999
 
 

Name:
Biogen Idec Inc.
Address:
14 Cambridge Center, Cambridge, MA 02142, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/08/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Grillo-Lopez Antonio
Address:
United States (US)

Priority

Priority Number:
96180 P
Priority Date:
11/08/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages